Source: Υπουργείο Υγείας (CY) Revision Year: 2019 Publisher: GlaxoSmithKline (Ireland) Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
Ventolin Nebules 2.5mg.
| Pharmaceutical Form |
|---|
|
Solution for inhalation via a nebuliser. |
Plastic ampoule containing 2.5 ml of a sterile 0.1% w/v solution of salbutamol (as Salbutamol Sulfate BP) in normal saline.
| Active Ingredient | Description | |
|---|---|---|
| Salbutamol |
Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the β2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases. |
| List of Excipients |
|---|
|
Sodium chloride |
Low density polyethylene ampoules available in boxes of 20 in strips of 5.
GlaxoSmithKline (Ireland) Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
17101
Date of first authorisation: 27 January 1998
Date of latest renewal: 12 March 2010
| Drug | Countries | |
|---|---|---|
| VENTOLIN | Australia, Canada, Cyprus, Estonia, Spain, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
